Brachytherapy treatment improves uterine cancer survival – study
An evaluation of the National Cancer Institute’s Surveillance, Epidemiology and End Results (SEER) database found that women with inoperable early-stage endometrial cancer have a better chance of survival if they undergo treatment that includes brachytherapy (BT) instead of external beam radiotherapy (EBRT) alone, Medscape revealed on April 27.
The study, which involved the analysis of 460 patients’ data from the SEER database, found that patients who took BT or BT with EBRT scored high in both 3-year overall survival and 3-year cause-specific survival. EBRT uses a radiation beam from outside the body to destroy cancer cells. BT, on the other hand, involves placing the source of radiation near the tumor to get rid of the cancer cells.
Women who have undergone a laparoscopic procedure involving power morcellators are at a higher risk of developing uterine cancer. To learn more about taking legal action against the manufacturer after being adversely affected by this medical device, consult with an attorney at Williams Kherkher by calling (800) 220-9341 today.